Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 185 citing articles:

Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang, Ji Nie, Xuelei Ma, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1319
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang, Qijie Dai, Xiaorui Su, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 6, pp. 4587-4629
Open Access | Times Cited: 471
PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
Rosalin Mishra, Hima Patel, Samar Alanazi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3464-3464
Open Access | Times Cited: 205
Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
Zhongren Xu, Jianqiang Xu, Shibo Sun, et al.
Redox Biology (2022) Vol. 54, pp. 102351-102351
Open Access | Times Cited: 86
Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Deniz Tümen, Philipp Heumann, Karsten Gülow, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3202-3202
Open Access | Times Cited: 86
Decoding hepatocarcinogenesis from a noncoding RNAs perspective
Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline Joseph Kiriacos, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 9, pp. 1982-2009
Closed Access | Times Cited: 56
Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155303-155303
Closed Access | Times Cited: 17
LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis
Yuqi Huang, Bo Xiang, Yuanhua Liu, et al.
Cancer Letters (2018) Vol. 437, pp. 56-66
Closed Access | Times Cited: 153
Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer
Weiyang Lou, Bisha Ding, Peifen Fu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 136
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
Jiguang Han, Baojuan Han, Xueya Wu, et al.
Toxicology and Applied Pharmacology (2018) Vol. 359, pp. 55-61
Closed Access | Times Cited: 119
PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma
Yuting Wu, Yingshi Zhang, Xiaochun Qin, et al.
Pharmacological Research (2020) Vol. 160, pp. 105195-105195
Closed Access | Times Cited: 108
Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial–mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway
Ye Lin, Zhixiang Jian, Haosheng Jin, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 81
The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma
Xuejiao Chen, Feng Ru Tang, Frank Arfuso, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 66-66
Open Access | Times Cited: 76
The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process
Soudeh Ghafouri‐Fard, Atefe Abak, Farhad Tondro Anamag, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111279-111279
Open Access | Times Cited: 59
Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma
Kai Zhang, Jing Chen, Chen Li, et al.
Cancer Letters (2021) Vol. 526, pp. 142-154
Closed Access | Times Cited: 59
PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
Qi Zhou, Leijia Li, Feifei Sha, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2372-2386
Open Access | Times Cited: 27
The role of long non-coding RNA in hepatocellular carcinoma
Weizheng Liang, Yan Zhao, Qingxue Meng, et al.
Aging (2024) Vol. 16, Iss. 4, pp. 4052-4073
Open Access | Times Cited: 9
LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis
Lei Zhang, Liang Wang, Yufeng Wang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 1140-1147
Open Access | Times Cited: 68
LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway
Jing Li, Mei-Rong He, Wen Xu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 60
Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA‐96
Yufeng Zhang, Haiyan Yang, Yong Du, et al.
Cancer Science (2019) Vol. 110, Iss. 9, pp. 2760-2772
Open Access | Times Cited: 59
<p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>
Tao Xu, Rui Zhang, Menglu Dong, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 10639-10650
Open Access | Times Cited: 56
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma
Jinlan Huang, Yansong Zheng, Xialin Xiao, et al.
Disease Markers (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 51
HCC and Molecular Targeting Therapies: Back to the Future
Luca Rinaldi, Erica Vetrano, Barbara Rinaldi, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1345-1345
Open Access | Times Cited: 42
LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway
Huan Yue, Kaifeng Wu, Kanglin Liu, et al.
Cellular Oncology (2022) Vol. 45, Iss. 3, pp. 447-462
Closed Access | Times Cited: 29
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top